Biology and therapeutic implications of the chemokine RANTES

A. M. Krensky*

*Corresponding author for this work

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

RANTES (regulated upon activation, normal T cell expressed and secreted) is a chemoattractant cytokine (chemokine) that is involved in the generation of inflammatory infiltrates and in the entry of the human immunodeficiency virus (HIV-1) into immune cells. It was first identified as part of a screen for genes expressed late (3-5 days) after T cell activation. It binds a variety of seven transmembrane spanning serpentine receptors expressed by monocytes, T lymphocytes, eosinophils, and basophils. RANTES has been implicated in a myriad of immune-mediated disease states, including asthma, delayed type hypersensitivity, arteriosclerosis, transplant rejection, rheumatoid arthritis, infections, and cancer. Downregulating RANTES expression may be therapeutic for inflammatory diseases, while upregulating RANTES expression may be useful for the treatment of the acquired immune defiency syndrome (AIDS) and/or cancer. Several novel approaches have used information on the structure and function of RANTES to develop new therapies. Chemokines as a group appear to be important targets for develpment of new immunotherapies.

Original languageEnglish (US)
Pages (from-to)16-21
Number of pages6
JournalAllergy and Clinical Immunology International
Volume11
Issue number1
StatePublished - Feb 4 1999

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Biology and therapeutic implications of the chemokine RANTES'. Together they form a unique fingerprint.

  • Cite this